Abstract
Cells from rat carcinoma cell lines PROb (giving progressive tumours) and REGb (giving regressive tumours) have cell surface receptors which bind specifically rat plasminogen and plasmin. Affinity for Pg was found to be higher in PROb (Kd = 10(-7) M) than in REGb cells (Kd = 5.10(-7) M) but with a concomitant decrease in the number of binding sites, 0.9 x 10(6)/cell (range from 0.6 to 1.2 x 10(6)) in PROb vs 3.6 x 10(6)/cell (range 1.2 to 6 x 10(6)) in REGb cells. The number and the affinity of binding sites varied in an opposite way in PROb and REGb cells. The difference in affinity parameters was unrelated to the degree of invasiveness of tumour cells in syngenetic rats. Bound plasmin retained its enzymatic activity, which indicates that its binding does not involve the catalytic active site. In cell solubilisates plasminogen receptor appeared as one major band situated in the area of 50-60 kDa.
Full text
PDF![51](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302b/1977915/32c7f61db7d6/brjcancer00059-0053.png)
![52](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302b/1977915/a64312c9d48a/brjcancer00059-0054.png)
![53](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302b/1977915/a00f656ee6ac/brjcancer00059-0055.png)
![54](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302b/1977915/7e7cc8b2530a/brjcancer00059-0056.png)
![55](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302b/1977915/6becce90e780/brjcancer00059-0057.png)
![56](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/302b/1977915/656515c43d89/brjcancer00059-0058.png)
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Appella E., Robinson E. A., Ullrich S. J., Stoppelli M. P., Corti A., Cassani G., Blasi F. The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. J Biol Chem. 1987 Apr 5;262(10):4437–4440. [PubMed] [Google Scholar]
- Burtin P., Chavanel G., Andre J. The plasmin system in human colonic tumors: an immunofluorescence study. Int J Cancer. 1985 Mar 15;35(3):307–314. doi: 10.1002/ijc.2910350305. [DOI] [PubMed] [Google Scholar]
- Burtin P., Chavanel G., André-Bougaran J., Gentile A. The plasmin system in human adenocarcinomas and their metastases. A comparative immunofluorescence study. Int J Cancer. 1987 Feb 15;39(2):170–178. doi: 10.1002/ijc.2910390208. [DOI] [PubMed] [Google Scholar]
- Burtin P., Fondaneche M. C. Receptor for plasmin on human carcinoma cells. J Natl Cancer Inst. 1988 Jul 20;80(10):762–765. doi: 10.1093/jnci/80.10.762. [DOI] [PubMed] [Google Scholar]
- Burtin P., Fondaneche M. C. Solubilization of the plasmin receptor from human carcinoma cells. Biochem Biophys Res Commun. 1990 Jul 31;170(2):748–754. doi: 10.1016/0006-291x(90)92154-r. [DOI] [PubMed] [Google Scholar]
- Camacho M., Fondaneche M. C., Burtin P. Limited proteolysis of tumor cells increases their plasmin-binding ability. FEBS Lett. 1989 Mar 13;245(1-2):21–24. doi: 10.1016/0014-5793(89)80183-8. [DOI] [PubMed] [Google Scholar]
- Correc P., Fondanèche M. C., Bracke M., Burtin P. The presence of plasmin receptors on three mammary carcinoma MCF-7 sublines. Int J Cancer. 1990 Oct 15;46(4):745–750. doi: 10.1002/ijc.2910460432. [DOI] [PubMed] [Google Scholar]
- Correc P., Zhang S., Komano O., Laurent M., Burtin P. Visualization of the plasmin receptor on carcinoma cells. Int J Cancer. 1992 Mar 12;50(5):767–771. doi: 10.1002/ijc.2910500517. [DOI] [PubMed] [Google Scholar]
- Durliat M., Komano O., Correc P., Burtin P. A receptor for plasminogen and plasmin on human and rat carcinoma cells. Evidence for strong interspecific reactivity. Thromb Res. 1991 Dec 15;64(6):637–645. doi: 10.1016/0049-3848(91)90064-4. [DOI] [PubMed] [Google Scholar]
- Estreicher A., Wohlwend A., Belin D., Schleuning W. D., Vassalli J. D. Characterization of the cellular binding site for the urokinase-type plasminogen activator. J Biol Chem. 1989 Jan 15;264(2):1180–1189. [PubMed] [Google Scholar]
- Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
- Martin F., Caignard A., Jeannin J. F., Leclerc A., Martin M. Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int J Cancer. 1983 Nov 15;32(5):623–627. doi: 10.1002/ijc.2910320517. [DOI] [PubMed] [Google Scholar]
- Miles L. A., Plow E. F. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells. Thromb Haemost. 1987 Oct 28;58(3):936–942. [PubMed] [Google Scholar]
- Mullins D. E., Rohrlich S. T. The role of proteinases in cellular invasiveness. Biochim Biophys Acta. 1983 Dec 29;695(3-4):177–214. doi: 10.1016/0304-419x(83)90011-2. [DOI] [PubMed] [Google Scholar]
- Ossowski L. Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo. Cell. 1988 Feb 12;52(3):321–328. doi: 10.1016/s0092-8674(88)80025-4. [DOI] [PubMed] [Google Scholar]
- Plow E. F., Freaney D. E., Plescia J., Miles L. A. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol. 1986 Dec;103(6 Pt 1):2411–2420. doi: 10.1083/jcb.103.6.2411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saksela O., Rifkin D. B. Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol. 1988;4:93–126. doi: 10.1146/annurev.cb.04.110188.000521. [DOI] [PubMed] [Google Scholar]
- Salo T., Liotta L. A., Keski-Oja J., Turpeenniemi-Hujanen T., Tryggvason K. Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells--role in metastasis. Int J Cancer. 1982 Nov 15;30(5):669–673. doi: 10.1002/ijc.2910300520. [DOI] [PubMed] [Google Scholar]